Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride Injection

Approval Number

国药准字H20067400

Company扬州中宝药业股份有限公司

Registration Date

September 9, 2021

Previous Approval Numbers

国药准字H20067400

Drug Information

Generic Name

盐酸昂丹司琼注射液

Dosage Form

注射剂

Strength

4ml:8mg(按C18H19N3O计)

Drug Type

化学药品

Registration Date

September 9, 2021

Company Information

Applicant Company

Company Name扬州中宝药业股份有限公司

Company Address

江苏省扬州市宝应县经济开发区新区宝应大道91号

Manufacturing Company

Company Name扬州中宝药业股份有限公司

Company Address

江苏省扬州市宝应县经济开发区新区宝应大道91号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸昂丹司琼注射液 - NMPA 批准文号 | MedPath